TNF and myeloproliferative neoplasm: Furthermore, MPN driver mutations trigger the activation of pro-inflammatory signaling pathways, particularly the tumor necrosis factor (TNF) and nuclear factor kappa-light-chain enhancer of activated B cells (NF-kB) pathways, in mutated hematopoietic stem cells (HSCs) and their progeny [13].